Summary
Due to its high specificity (90%) and sensitivity (86%) measurement of CA125 has become well-established in patients with epithelial ovarian cancer. We have formulated a CA125 prognostic score and examined its validity as an additional prognosis index. This score is composed of two CA125 values (one determined preoperatively and one 1 month after operation). CA125 serum levels of 0–64 IU/ml received 1 point, levels of 65–299 IU/ml were given 2 points, and those >300 IU/ml were given 3 points. These points are added to produce the CA125 prognostic score. Statistical comparison demonstrated that patients with scores of 2 or 3 had a significantly (P=0.0005) better prognosis than patients with scores of 4, 5 or 6. The classical prognostics features such as the FIGO stage, residual tumor mass and ascites were found to correlate with the CA125 prognostic score.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Anonymous (1981) Evaluation of the cancer patient and the response to treatment. In: Monfardini S, Brunner K, Crowther D et al. (eds) Manual of cancer therapy. UICC, Geneva, pp 17–26
Bast RC, Klug TL, John ESt, Jenison E, Niloff J, Lazarus H, Berkowitz R, Leavitt T, Griffiths C, Parker L, Zurawski VR, Knapp RC (1983) A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 309:883–887
Berek JS, Hacker NF, Lagasse LD, Nieberg RK, Elashoff RM (1983) Survival of patients following secondary cytoreductive surgery in ovarian cancer. Obstet Gynecol 61:189–193
Cox DR (1972) Regression models and life tables. J R Stat Soc B 34:187–220
Crombach G, Zippel HH, Würz H (1985) Erfahrungen mit CA125, einem Tumormarker für maligne epitheliale Overialtumoren. Geburtsh Frauenheilkd 45:205–212
Day TG, Gallager HS, Rutledge FN (1975) Epithelial carcinoma of the ovary: the prognostic importance of histologic grade. Natl Cancer Inst Monogr 42:15–21
Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481
Klug TL, Bast R, Niloff J, Knapp R, Maroski V (1984) Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA125) associated with human epithelial ovarian carcinomas. Cancer Res 44:1048–1053
Mantel N (1986) Evaluation of survival data and two new rank order statistics arising in its considerations. Cancer Chemother Rep 50:163–170
Parker D et al. (1988) CA125 and survival in ovarian cancer: preliminary communication. J Royal Soc Ned 8:22
Serov SF, Scull RE, Sarbin LH (1973) Histological typing of ovarian tumors. WHO, Geneva, p 17
Sevelda P, Salzer H, Dittrich Ch, Pateisky N, Spona J (1987) The diagnostic validity of the tumor marker CA125 in ovarian cancer patients. Tumor Diagnostik Ther 8:115–120
Sevelda P, Salzer H, Dittrich Ch, Spona J (1985) Die klinische Bedeutung des Tumormarkers CA125 für die präoperative Diagnostik und die postoperative Nachbetreuung von Patientinnen mit malignen Ovarialtumoren. Geburtsh Frauenheilkd 45:769–773
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rosen, A., Sevelda, P., Klein, M. et al. A CA125 score as a prognostic index in patients with ovarian cancer. Arch Gynecol Obstet 247, 125–129 (1990). https://doi.org/10.1007/BF02390860
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02390860